158 related articles for article (PubMed ID: 27007877)
21. Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.
Lin GJ; Jiang GB; Xie YY; Huang HL; Liang ZH; Liu YJ
J Biol Inorg Chem; 2013 Dec; 18(8):873-82. PubMed ID: 23989405
[TBL] [Abstract][Full Text] [Related]
22. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
[TBL] [Abstract][Full Text] [Related]
24. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway.
Wang H; Sun N; Li X; Li K; Tian J; Li J
Oncol Rep; 2016 Jun; 35(6):3648-58. PubMed ID: 27035545
[TBL] [Abstract][Full Text] [Related]
25. Selenocysteine inhibits human osteosarcoma cells growth through triggering mitochondrial dysfunction and ROS-mediated p53 phosphorylation.
Wang W; Meng FB; Wang ZX; Li X; Zhou DS
Cell Biol Int; 2018 May; 42(5):580-588. PubMed ID: 29323455
[TBL] [Abstract][Full Text] [Related]
26. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.
Zhao J; Li S; Wang X; Xu G; Gou S
Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781
[TBL] [Abstract][Full Text] [Related]
27. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
[TBL] [Abstract][Full Text] [Related]
28. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis.
Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ
J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205
[TBL] [Abstract][Full Text] [Related]
29. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes.
Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530
[TBL] [Abstract][Full Text] [Related]
30. DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex.
Zhang P; Chen J; Liang Y
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):440-9. PubMed ID: 20705582
[TBL] [Abstract][Full Text] [Related]
31. Vitamin K4 inhibits the proliferation and induces apoptosis of U2OS osteosarcoma cells via mitochondrial dysfunction.
Di W; Khan M; Gao Y; Cui J; Wang D; Qu M; Feng L; Maryam A; Gao H
Mol Med Rep; 2017 Jan; 15(1):277-284. PubMed ID: 27959452
[TBL] [Abstract][Full Text] [Related]
32. Chiral ruthenium complexes induce apoptosis of tumor cell and interact with bovine serum albumin.
Yuan F; Chen X; Liu Y; Zhang T; Sun D; Liu J
Chirality; 2012 Feb; 24(2):174-80. PubMed ID: 22180296
[TBL] [Abstract][Full Text] [Related]
33. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization and ROS-mediated antitumor effects of palladium(II) complexes of curcuminoids.
Li Y; Gu Z; Zhang C; Li S; Zhang L; Zhou G; Wang S; Zhang J
Eur J Med Chem; 2018 Jan; 144():662-671. PubMed ID: 29289889
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
[TBL] [Abstract][Full Text] [Related]
36. Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.
Zhang Z; Gou Y; Wang J; Yang K; Qi J; Zhou Z; Liang S; Liang H; Yang F
Eur J Med Chem; 2016 Oct; 121():399-409. PubMed ID: 27309677
[TBL] [Abstract][Full Text] [Related]
37. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, visible light photocleavage, antiproliferative and cellular uptake properties of ruthenium complex [Ru(phen)2(mitatp)]2+.
Yu HJ; Chen Y; Yu L; Hao ZF; Zhou LH
Eur J Med Chem; 2012 Sep; 55():146-54. PubMed ID: 22841281
[TBL] [Abstract][Full Text] [Related]
39. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
40. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]